methylprednisolone hemisuccinate has been researched along with POEMS Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyett, JM | 1 |
| Arimura, K; Eiraku, N; Hashiguchi, T; Maruyama, I; Osame, M; Tokashiki, T | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and POEMS Syndrome
| Article | Year |
|---|---|
What's wrong with this patient? POEMS syndrome.
Topics: Acyclovir; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Bone Marrow Examination; Drug Therapy, Combination; Edema; Fatigue; Gait; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Paresthesia; Pigmentation Disorders; POEMS Syndrome; Prognosis; Remission Induction; Rituximab | 2003 |
Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome.
Topics: Antithrombins; Arginine; Disseminated Intravascular Coagulation; Glucocorticoids; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Pipecolic Acids; Platelet Count; POEMS Syndrome; Predictive Value of Tests; Sulfonamides; Vascular Endothelial Growth Factor A | 2003 |